U.S. Other Utilities Stock News

BridgeBio Pharma has announced that long-term efficacy and safety results from the open-label extension of its Phase 3 ATTRibute-CM trial of acoramidis in ATTR-CM, including multiple analyses on survival, disease stabilization, and patient-reported outcomes, were presented at the American College of Cardiology Annual Scientific Sessions in New Orleans on March 28–30, 2026. The new data, alongside real-world survey findings on treatment patterns and preferences in ATTR-CM, offer a deeper view...

If you are wondering whether Global-E Online is starting to look attractive or still carries too much risk, its recent share price moves and current valuation metrics give you plenty to think about. The stock last closed at US$28.93, with returns of a 10.5% decline over 7 days, a 17.6% decline over 30 days, a 23.6% decline year to date and an 18.9% decline over 1 year. These moves may have shifted how the market is pricing its prospects and risks. These moves have come as Global-E Online...

Why Stagwell’s HarrisQuest Expansion Matters for Investors Stagwell (STGW) recently expanded The Harris Poll’s HarrisQuest platform across Europe, giving regional brands access to always on, data driven brand and reputation tracking that global companies already use for key marketing decisions. See our latest analysis for Stagwell. Stagwell’s recent HarrisQuest expansion and focus on artificial intelligence backed services comes as the shares trade at US$6.08, with a 30 day share price return...

H.B. Fuller (NYSE:FUL) secured key raw materials after more than 40 force majeure notices linked to Middle East related supply disruptions. The company plans a minimum 10% global price increase effective April 1, 2026, to address inflation and raw material cost pressures. Management has paused acquisitions to focus on debt reduction and share buybacks, which signals a shift in capital allocation priorities. For investors watching NYSE:FUL, the share price sits at $59.17, with a 20.0% gain...

In March 2026, Alteogen announced an exclusive license deal giving Biogen rights to develop subcutaneous formulations for two biologic products using ALT-B4 Hybrozyme technology, while new data from Eisai and Biogen showed strong long-term real-world treatment persistence for intravenous lecanemab in Alzheimer’s patients. Together, these developments highlight Biogen’s push to expand patient-friendly biologic delivery and deepen its presence in Alzheimer’s care through therapies patients are...

Recently, RingCentral reported solid quarterly results, but weaker billings and softer demand indicators have raised fresh questions about the strength of its underlying growth engine. An unusual red flag is the negative customer acquisition cost payback period, suggesting current sales and marketing spending may not be efficiently converting into profitable, long-term customers. Next, we'll explore how concerns over weak billings and soft demand could reshape RingCentral's existing...

Herbalife (HLF) is back on investors' radar after recent share price pressure, with the stock showing a 25.2% decline over the past month following an earlier 8.1% gain in the past 3 months. See our latest analysis for Herbalife. At a share price of $14.41, Herbalife’s recent 1 month share price return of a 25.2% decline contrasts with a 12.4% year to date share price gain and a 68.14% 1 year total shareholder return. This suggests that momentum has recently faded after a stronger run. If...

Why Danaher (DHR) Is Drawing Attention Now Danaher (DHR) is back on many watchlists after a period of weaker share performance, including a 13% decline over the past month and a 21% decline over the past 3 months. See our latest analysis for Danaher. At a share price of $181.52, Danaher’s recent 13% 1 month share price decline and 21% 3 month share price decline extend a tougher run, while the 1 year total shareholder return of 11% and 5 year total shareholder return of 7% indicate pressure...

Revvity (NYSE:RVTY) plans to hold its annual meeting on April 28, 2026. Shareholders will vote on a proposed bylaw change to let holders of 25% of shares call special meetings. Activist-backed proposals seek tighter executive stock retention requirements tied to equity compensation. Revvity, which operates in life sciences and diagnostics, sits in a sector where governance practices are closely watched, partly because R&D cycles and regulatory oversight can shape capital allocation...

Recent share price weakness in Ralph Lauren (RL), including a month return of about 13% and roughly 8% over the past 3 months, has drawn fresh attention to how investors are weighing its current valuation and fundamentals. See our latest analysis for Ralph Lauren. At a share price of $327.82, Ralph Lauren’s recent 1 month share price return of about 13% and 3 month share price return of roughly 8% sit against a 1 year total shareholder return of 53.8%. This suggests momentum has cooled...

Event context and recent stock performance Costco Wholesale (COST) has drawn fresh attention after recent trading left the shares with a small one-day gain and a modest rise over the past week, while the month shows a slight negative return. See our latest analysis for Costco Wholesale. Set against a 12.65% 90 day share price return and a 15.14% year to date share price return, Costco Wholesale’s recent moves suggest momentum has been building. The 3 year total shareholder return of 106.23%...

In its most recent quarter, First American Financial posted an exceptional performance with revenue rising 21.6% year on year, beating analyst forecasts by 15.2% and signaling strong recent business momentum. This combination of solid top-line growth and outperformance versus expectations highlights how the company’s operations have recently been executing ahead of what the market had modeled. We’ll now examine how this stronger-than-expected quarterly revenue performance might influence...

Why DHT Holdings Filed a New Shelf Registration DHT Holdings (DHT) has filed an omnibus shelf registration covering common stock, preferred stock, warrants, and rights. This filing gives the tanker owner flexibility to raise capital or pursue corporate actions when market conditions appear suitable. See our latest analysis for DHT Holdings. The shelf registration comes after a strong run, with DHT’s 90-day share price return of 48.12% and year-to-date gain of 54.17%, while the 1-year total...

In recent days, Intercontinental Exchange, Inc. completed a new US$600 million cash investment in prediction market platform Polymarket and reported record trading activity across its global derivatives and NYSE equities markets following geopolitical tensions in the Middle East. Together, these moves underscore how ICE is pairing high-intensity usage of its existing trading infrastructure with experimental exposure to emerging prediction markets. We’ll now examine how ICE’s expanded...

If you are wondering whether eToro Group at around US$29.05 is a bargain or a value trap, this breakdown is designed to help you frame that question clearly. The share price closed at US$29.05, with a 1.3% decline over the past week, a 10.5% decline over the past month, and an 18.6% decline year to date, which may signal shifting views on both risk and potential. Recent coverage has focused on eToro Group as a publicly listed trading platform provider that gives investors access to a wide...

Earlier this month, Varonis Systems unexpectedly announced it will discontinue its on-premises solution, which contributed about 15% of revenue, after missing quarterly projections and shifting its focus more fully to its SaaS platform. At the same time, the company launched its new Varonis Atlas AI security platform and prepared high-profile presentations at RSA Conference 2026, underscoring a quicker pivot toward AI-driven, cloud-based data security. We’ll now examine how the accelerated...

If you are wondering whether Cabot's current share price reflects its true worth, this article breaks down the key valuation clues you can use to judge it for yourself. Cabot recently closed at US$74.11, with returns of 9.3% over the past week, a 2.3% decline over the past month, 10.5% year to date and a 7.7% decline over the past year. Taken together, these figures give mixed signals about how the market is currently pricing the stock. Recent coverage around Cabot has focused on its...

Novo Nordisk (NYSE:NVO) has received an FDA National Priority Voucher tied to a higher dose of its obesity drug Wegovy. This is the fourth such voucher granted for the higher dose version, marking another key regulatory step for the product. The decision comes as the FDA prepares a June public meeting to review and discuss the controversial priority voucher program. Lawmakers have called for more transparency around how these vouchers are awarded and used, which could influence future...

The Trade Desk (NasdaqGM:TTD) has appointed Drew Vollero to its board of directors. Vollero is a financial executive with IPO experience at Reddit and Snap. The appointment comes during a period of governance scrutiny and industry headwinds for The Trade Desk. The Trade Desk operates a digital advertising platform that helps brands and agencies buy ad inventory across channels such as connected TV, online video, and display. The broader ad tech space has been dealing with regulatory...

Wondering if PTC Therapeutics at around US$66.13 is giving you a fair deal or asking too much for its future potential? This article breaks down what the current price might be implying. The stock has seen a mixed run recently, with a 1.3% gain over the last 7 days, a 2.4% decline over 30 days, a 13.8% decline year to date, a 21.9% return over 1 year, and 36.5% and 34.4% over 3 and 5 years respectively. Recent attention on PTC Therapeutics has centered on how investors are reassessing the...

Wondering if Generac Holdings at around US$194 per share still offers value, or if the easy gains are already behind it? This article focuses squarely on what the current price implies. The stock has had a mixed run, with a 2.5% decline over the last week and a 17.8% decline over the last month, while still sitting on returns of 37.8% year to date and 53.0% over the past year. Recent coverage of Generac has highlighted renewed interest in companies linked to backup power and grid resilience...

For readers wondering whether Brunswick's share price still offers value after a strong run, or if most of the potential upside is already reflected, this article focuses on what the numbers indicate about its valuation. Brunswick closed at US$70.95, with a 0.7% return over the last 7 days, a 12.4% decline over 30 days, a 6.5% decline year to date, and a 36.2% gain over 1 year. Over 3 years and 5 years the returns were declines of 7.3% and 19.0% respectively. Recent price moves are set...

On March 13, 2026, Liquidia’s Chief Medical Officer Rajeev Saggar sold 35,365 shares of common stock for about US$1.28 million, trimming roughly one sixth of his direct holdings. This sizeable insider sale comes while Liquidia’s core business appears to be progressing, highlighted by YUTREPIA’s reach to more than 2,900 patients and two straight profitable quarters. We’ll now examine how this sizeable insider sale amid ongoing YUTREPIA momentum may influence Liquidia’s broader investment...

Lightwave Logic, Inc. has released its full-year 2025 results, reporting sales of US$236,855 compared with US$95,605 a year earlier, alongside a net loss of US$20.31 million versus US$22.54 million and a basic loss per share from continuing operations of US$0.16 compared with US$0.19. The figures point to early commercial traction and a reduced loss profile, which may influence how investors assess the company’s progress toward scaling its technology platform. Against this backdrop, we will...